Literature DB >> 1424750

Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review.

J W Streilein1, G A Wilbanks, A Taylor, S Cousins.   

Abstract

The normal aqueous humor contains a variety of soluble immunosuppressive factors, including transforming growth factor-beta, alpha-melanocyte stimulating hormone, and vasoactive intestinal peptide. These factors are largely the secretory products of parenchymal cells of the iris and ciliary body. TGF beta has recently been shown to alter the functional capacity of intraocular antigen presenting cells, such that they are capable of inducing Anterior Chamber Associated Immune Deviation (ACAID). This deviant systemic immune response is characterized by an impaired capacity to mount an effective cell-mediated immune attack directed at antigens that are placed in, or arise within, the eye. A second property of immunosuppressive factors in aqueous humor is to suppress directly the expression of delayed hypersensitivity in the anterior chamber. In fact, even when the intraocular microenvironment is disturbed by local instillation of gamma-interferon, making it possible for limited expression of cell-mediated immunity in the eye, the microenvironment of the anterior chamber remains profoundly immunosuppressive. In this latter instance, prostaglandins replace TGF beta as the major molecular mediators of suppression in the aqueous humor. In the aggregate, factors present in the normal (or perturbed) intraocular microenvironment have the capacity to modify both the afferent and efferent limbs of the systemic immune response, and this accounts for the longstanding observation that the anterior chamber is an immunologically privileged site. Since evidence suggests that the eye can mobilize more than one molecular mechanism in its effort to limit the sight-destroying potential of immunogenic inflammation, we believe that elucidation of intraocular cytokines and factors that create and maintain an immunosuppressive microenvironment will contribute to a better understanding of the pathogenesis of the acute and chronic uveitides, especially those of autoimmune and infectious etiology.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424750     DOI: 10.3109/02713689208999510

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  10 in total

Review 1.  Immune mechanisms in uveitis.

Authors:  R R Caspi
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Fuchs' heterochromic cyclitis: review of the literature on the pathogenetic mechanisms.

Authors:  E La Hey; P T de Jong; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

3.  Bilateral hyphaema following diode laser for retinopathy of prematurity.

Authors:  P Rundle; F G McGinnity
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

4.  Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.

Authors:  J D Isaacs; G Hale; H Waldmann; A D Dick; R Haynes; J V Forrester; P Watson; P A Meyer
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

Review 5.  Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?

Authors:  A D Dick
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

6.  Lipopolysaccharide/interferon-gamma and not transforming growth factor beta inhibits retinal microglial migration from retinal explant.

Authors:  D A Carter; A D Dick
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

7.  Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections.

Authors:  K Geiger; E L Howes; N Sarvetnick
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

Authors:  C Yee; J A Thompson; P Roche; D R Byrd; P P Lee; M Piepkorn; K Kenyon; M M Davis; S R Riddell; P D Greenberg
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

Review 9.  The eye as a novel imaging site in diabetes research.

Authors:  Shao-Nian Yang; Per-Olof Berggren
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 10.  Plasmacytoid dendritic cells in the eye.

Authors:  Arsia Jamali; Brendan Kenyon; Gustavo Ortiz; Abdo Abou-Slaybi; Victor G Sendra; Deshea L Harris; Pedram Hamrah
Journal:  Prog Retin Eye Res       Date:  2020-07-24       Impact factor: 21.198

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.